Cigna Investments’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
Other funds holding GHDX
BBA
AAM
MF
Cigna Investments's GHDX Position: Q3 2019 in Review
Cigna Investments sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 7,176 shares — an estimated $524K sold.
Cigna Investments first reported a position in GHDX in Q3 2018 and held it in 4 quarters. The position peaked at $612K in Q3 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.
- Cigna Investments reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
- Cigna Investments sold 7,176 Genomic Health, Inc. shares in Q3 2019, an estimated $524K.
- Cigna Investments first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 4 quarters.
- Cigna Investments's Genomic Health, Inc. position peaked at $612K in Q3 2018.
- 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.
Based on Cigna Investments's 13F filing for Q3 2019, filed 7 Nov 2019.